Literature DB >> 20637912

SUMOylation can regulate the activity of ETS-like transcription factor 4.

Sanna Kaikkonen1, Harri Makkonen, Miia Rytinki, Jorma J Palvimo.   

Abstract

ETS-like transcription factor 4 (ELK4) (a.k.a. serum response factor accessory protein 1) belongs to the ternary complex factor (TCF) subfamily of E twenty-six (ETS) domain transcription factors. Compared to the other TCF subfamily members, ELK1 and ELK3 (NET), there is limited information of the mechanisms regulating the ELK4 activity. Here, we show that the ELK4 can be covalently modified (SUMOylated) by small ubiquitin-related modifier (SUMO) 1 protein, an important regulator of signaling and transcription. SUMOylation of ELK4 was reversed by SUMO-specific proteases (SENP) 1 and 2 and stimulated by SUMO E3 ligase PIAS3. Conserved lysine residue 167 that is located in the NET inhibitory domain of ELK4 was identified as the main site of SUMO-1 conjugation. Interestingly, mutation of the K167 disrupting the SUMOylation markedly enhanced the transcriptional activity of the ELK4, but weakened its repressive function on c-fos promoter. In conclusion, our results suggest that covalent modification by SUMO-1 can regulate the activity of ELK4, contributing to the transcriptional repression by the ELK4.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637912     DOI: 10.1016/j.bbagrm.2010.07.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Ubc9 Is Required for Positive Selection and Late-Stage Maturation of Thymocytes.

Authors:  Aibo Wang; Xiao Ding; Maud Demarque; Xindong Liu; Deng Pan; Huawei Xin; Bo Zhong; Xiaohu Wang; Anne Dejean; Wei Jin; Chen Dong
Journal:  J Immunol       Date:  2017-03-17       Impact factor: 5.422

Review 2.  Function and regulation of SUMO proteases.

Authors:  Christopher M Hickey; Nicole R Wilson; Mark Hochstrasser
Journal:  Nat Rev Mol Cell Biol       Date:  2012-12       Impact factor: 94.444

3.  SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.

Authors:  Matthew F Barber; Eriko Michishita-Kioi; Yuanxin Xi; Luisa Tasselli; Mitomu Kioi; Zarmik Moqtaderi; Ruth I Tennen; Silvana Paredes; Nicolas L Young; Kaifu Chen; Kevin Struhl; Benjamin A Garcia; Or Gozani; Wei Li; Katrin F Chua
Journal:  Nature       Date:  2012-07-05       Impact factor: 49.962

4.  An in vivo screen to identify candidate neurogenic genes in the developing Xenopus visual system.

Authors:  Jennifer E Bestman; Lin-Chien Huang; Jane Lee-Osbourne; Phillip Cheung; Hollis T Cline
Journal:  Dev Biol       Date:  2015-03-27       Impact factor: 3.582

5.  SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma.

Authors:  Hye Seung Lee; Wonkyung Jung; Eunjung Lee; Hyeyoon Chang; Jin Hyuk Choi; Han Gyeom Kim; Aeree Kim; Baek-Hui Kim
Journal:  J Pathol Transl Med       Date:  2016-08-05

6.  HCG11 up-regulation induced by ELK4 suppressed proliferation in vestibular schwannoma by targeting miR-620/ELK4.

Authors:  Ruiqing Long; Zhuohui Liu; Jinghui Li; Yuan Zhang; Hualin Yu
Journal:  Cancer Cell Int       Date:  2021-01-05       Impact factor: 5.722

7.  ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis.

Authors:  Lei Zheng; Hongmei Xu; Ya Di; Lanlan Chen; Jiao Liu; Liying Kang; Liming Gao
Journal:  J Transl Med       Date:  2021-08-09       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.